Free Trial
LON:GENI

GENinCode (GENI) Share Price, News & Analysis

GENinCode logo
GBX 4.15 0.00 (0.00%)
(As of 11/21/2024 ET)

About GENinCode Stock (LON:GENI)

Key Stats

Today's Range
4
4.18
50-Day Range
3.83
6.87
52-Week Range
3.34
10
Volume
179,617 shs
Average Volume
200,928 shs
Market Capitalization
£7.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies. The company's molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a patented genetic test to help user to adopt cardiovascular prevention steps; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia; SUDD inCode, a genetic test to diagnose the cause of sudden cardiac death and familial heart disease; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis; and Thrombo inCode Reproductive Health, a genetic test that offers information related to risk of thrombophilia and associated risks for future pregnancies. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.

Receive GENI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter.

GENI Stock News Headlines

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Amundi Msci Em Share Chat
Usa Qual Usd-d Share Chat
Bank Mont.29 A Share Chat
See More Headlines

GENI Stock Analysis - Frequently Asked Questions

GENinCode's stock was trading at GBX 5.25 on January 1st, 2024. Since then, GENI stock has decreased by 21.0% and is now trading at GBX 4.15.
View the best growth stocks for 2024 here
.

Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that GENinCode investors own include QUALCOMM (QCOM), Sound Energy (SOU), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID) and Plug Power (PLUG).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Entertainment
CIK
N/A
Fax
N/A
Employees
2,300
Year Founded
N/A

Profitability

Net Income
£-5,940,000.00
Net Margins
-228.70%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.60 million
Cash Flow
GBX 4.98 per share
Book Value
GBX 2 per share

Miscellaneous

Free Float
N/A
Market Cap
£7.34 million
Optionable
Not Optionable
Beta
0.66
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (LON:GENI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners